American Society of Clinical Oncology

SHERPA: White

People

  1. Traina
    Traina
  2. Hudis
    Hudis
  3. Norton
    Norton
  4. Feigin
    Feigin
  5. Gucalp
    Gucalp
  6. Dang
    Dang
  7. Fornier
    Fornier
  8. Lake
    Lake
  9. Modi
    Modi
  10. D'Andrea-Carlino
    D'Andrea-Carlino

Groups

  1. Biostatistics Service (19)
  2. Breast Medicine Service (19)
  3. Department of Medicine (19)
  4. Epidemiology and Biostatistics (19)
  5. Solid Tumor Oncology Division (19)
  6. Survivorship Research (19)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (9)
  8. Body Imaging Service (7)
  9. Breast Imaging Service (7)
  10. Population Sciences Research Program (7)
Search Within
  1. "Sujata Patil"
  2. "Tiffany Traina"
Formats
  1. Meeting Abstract (17)
  2. Journal Article (2)
Groups
  1. Biostatistics Service (19)
  2. Breast Medicine Service (19)
  3. Department of Medicine (19)
  4. Epidemiology and Biostatistics (19)
  5. Solid Tumor Oncology Division (19)
  6. Survivorship Research (19)

More Groups

People
  1. Sujata Patil (19)
  2. Tiffany Traina (19)
  3. Clifford Hudis (13)
  4. Larry Norton (8)
  5. Maria Theodoulou-Haber (8)
  6. Ayca Gucalp (6)

More People

Years
  1. 2020 (1)
  2. 2019 (1)
  3. 2018 (2)
  4. 2016 (2)
  5. 2015 (2)
  6. 2014 (1)

More Years

Publications
  1. Journal of Clinical Oncology (19)

Results (19)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of bicalutamide in combination with palbociclib for the treatment of androgen receptor (+) metastatic breast cancer
    Meeting Abstract

    Gucalp, A.; Boyle, L. A.; Alano, T.; Arumov, A.; Gounder, M. M.; Patil, S.; Feigin, K.; Edelweiss, M.; D'Andrea, G.; Bromberg, J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Adjuvant enzalutamide for the treatment of early-stage androgen receptor-positive (AR plus ) TNBC
    Meeting Abstract

    Traina, T. A.; Boyle, L. A.; Arumov, A.; Patil, S.; Edelweiss, M.; DeFusco, P. A.; Gorsky, M.; Lamparella, N. E.; Modi, S.; Sanford, R. A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Poly(ADP-Ribose) Polymerase Inhibitors (PARPi) for patients (pts) with locally advanced or metastatic breast cancer (BC): A meta-analysis
    Meeting Abstract

    Tio, M.; Patil, S.; Traina, T. A.; Robson, M. E.; Khasraw, M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Safety and tolerability of adjuvant enzalutamide for the treatment of early stage androgen receptor positive (AR+) triple negative breast cancer
    Meeting Abstract

    Lyons, T.; Gucalp, A.; Arumov, A.; Patil, S.; Edelweiss, M.; Gorsky, M.; Troso-Sandoval, T. A.; Bromberg, J.; Sanford, R. A.; Iyengar, N. M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Pilot trial of an implantable microdevice for in vivo drug sensitivity testing in patients with early stage, triple negative breast cancer receiving neoadjuvant therapy
    Meeting Abstract

    Traina, T. A.; Plitas, G.; Reis-Filho, J. S.; Morris, E. A.; Hughes, M.; Sung, J. S.; Patil, S.; Piscuoglio, S.; Park, S.; Greenberg, C.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase I/II trial of palbociclib in combination with bicalutamide for the treatment of androgen receptor (AR)+ metastatic breast cancer (MBC)
    Meeting Abstract

    Gucalp, A.; Proverbs-Singh, T. A.; Corben, A.; Moynahan, M. E.; Patil, S.; Boyle, L. A.; Hudis, C. A.; Traina, T. A.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer (MBC): Updated progression-free survival with overall survival result
    Meeting Abstract

    Smyth, L. M.; Iyengar, N. M.; Chandarlapaty, S.; Sugarman, S.; Comen, E. A.; Drullinsky, P.; Sklarin, N. T.; Traina, T. A.; Troso-Sandoval, T. A.; Patil, S.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Prevalence of hypomagnesemia in patients with HER2-positive breast cancer receiving pertuzumab treatment
    Meeting Abstract

    Proverbs-Singh, T. A.; Cadoo, K. A.; Torre, G.; Patil, S.; Gucalp, A.; Dang, C. T.; Hudis, C. A.; Glezerman, I. G.; Traina, T. A.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II feasibility study of paclitaxel (T) with trastuzumab (H) and lapatinib (L) for node-negative, HER2-positive breast cancer (BC)
    Meeting Abstract

    Iyengar, N. M.; Fornier, M. N.; Sugarman, S.; Theodoulou, M.; Troso-Sandoval, T. A.; D'Andrea, G.; Drullinsky, P.; Fasano, J.; Gajria, D.; Goldfarb, S. B.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • TBCRC 019: An open label, randomized, phase II trial of nanoparticle albumin-bound paclitaxel (nab-PAC) with or without the anti-death receptor 5 (DR5) monoclonal antibody tigatuzumab (TIG) in patients with metastatic triple negative breast cancer (TNBC)
    Meeting Abstract

    Vakiavas, C.; Abramson, V. G.; Lin, N. U.; Liu, M. C.; Rugo, H. S.; Nanda, R.; Storniolo, A. M.; Traina, T. A.; Li, Y.; Patil, S.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save